Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer.
Creemers GJ, Gerrits CJ, Schellens JH, Planting AS, van der Burg ME, van Beurden VM, de Boer-Dennert M, Harteveld M, Loos W, Hudson I, Stoter G, Verweij J.
Creemers GJ, et al. Among authors: van beurden vm, van der burg me.
J Clin Oncol. 1996 Sep;14(9):2540-5. doi: 10.1200/JCO.1996.14.9.2540.
J Clin Oncol. 1996.
PMID: 8823333
Clinical Trial.